Top Markets
Coin of the day
Clearbridge Health Limited Clearbridge Health Limited

Clearbridge Health Limited

1H3
Rank in Stocks #32398
Established in 2010 and headquartered in Singapore, Clearbridge Health Limited... Established in 2010 and headquartered in Singapore, Clearbridge Health Limited operates as an investment holding company, delivering diverse healthcare solutions globally, including in Singapore, the Philippines, Hong Kong, and Malaysia. The firm's activities are organized into three key divisions: Strategic Investments, Healthcare Systems, and Medical Clinics/Centres. Its extensive range of services encompasses advanced imaging diagnostics, such as general X-ray, CT scans (including dental cone beam), mammography, MRI, and ultrasound. Furthermore, Clearbridge offers general wellness screenings for conditions like diabetes, high blood pressure, and elevated cholesterol, alongside vaccination programs. Specialized care includes renal treatment, clinical services, aesthetic procedures, and dental and orthodontic services. Beyond patient care, the company provides consultancy to healthcare organizations and is involved in the wholesale supply of medicinal and pharmaceutical products.
Share Price
$0.00158262
Last synced: 2026-08-17
Market Cap
$10.20M
Change (1 day)
0.00%
Change (1 year)
-
Country
SG
Trade Clearbridge Health Limited (1H3)

Category

Revenue for Clearbridge Health Limited (1H3)
Revenue in Aug 2026 TTM: 0
According to Clearbridge Health Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Clearbridge Health Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.34B -
US
$25.11B -
US
- -
CN
$2.71B -
US
$4.55B -
US